Stable anti-CD79B immunoconjugate formulations
Abstract:
The disclosure provides stable pharmaceutical compositions comprising an anti-CD79b immunoconjugate and a surfactant. The disclosure also provides methods for using such compositions for the treatment of cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0